Introduces the only cloud-native MBD capability built into the core modeling experience, fully integrated within CAD and PDM Creates a single, always-up-to-dateIntroduces the only cloud-native MBD capability built into the core modeling experience, fully integrated within CAD and PDM Creates a single, always-up-to-date

PTC’s Onshape Launches Cloud-Native Model-Based Definition Capabilities

2026/02/26 21:46
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]
  • Introduces the only cloud-native MBD capability built into the core modeling experience, fully integrated within CAD and PDM
  • Creates a single, always-up-to-date product definition by embedding manufacturing information directly in the live 3D model
  • Improves collaboration and change control across engineering and manufacturing

BOSTON, Feb. 26, 2026 /PRNewswire/ — PTC (NASDAQ: PTC) today announced the release of a fully cloud-native Model-Based Definition (MBD) capability, built directly into its Onshape® computer-aided design (CAD) and product data management (PDM) platform. The new capability allows engineering teams to add manufacturing information directly into the 3D model early in the design process, enabling clearer design intent, fewer handoffs, and improved efficiency across design, documentation, manufacturing, and quality.

In traditional file-based CAD and PDM systems, manufacturing data is spread across drawings, exports, and disconnected files. This approach makes product definition harder to keep current, accessible, and trustworthy. The Onshape cloud-native platform, built on Amazon Web Services (AWS), helps eliminate these challenges by allowing teams to work from the same, always‑up‑to‑date product definition, enabling reduced errors and accelerated design‑to‑production workflows.

“When you build aircraft under strict regulatory oversight, ambiguity is expensive,” said Marc Germain, Chief Digital Officer at Aura Aero. “As an early user of MBD in Onshape, being able to carry certification and manufacturing requirements inside the model instead of across drawings and files is already cutting rework and review cycles and helping our teams work faster with fewer handoffs.”

“Onshape Model-Based definition is a great example of how AWS and PTC are working together to modernize engineering,” said Michael Choe, AWS General Manager, US Automotive and Manufacturing. “By re-architecting core engineering tools on AWS’ cloud-native platforms, we’re unlocking new possibilities—making them easier to deploy globally, more powerful through AI-driven capabilities, and dramatically better at enabling friction-free, real-time collaboration across distributed teams. This strategic collaboration represents a major leap forward in how teams design, build, and bring products to market.”

Key MBD capabilities include:

  • Integrated 3D Annotations: Engineers can embed GD&T, weld symbols, and datums directly into the 3D model, clearly communicating design intent without relying on separate 2D drawings.
  • Smart Inspection Panel: All product manufacturing information (PMI) is automatically organized into a structured, filterable list, with instant cross-highlighting to the related geometry in the model.
  • Shareable MBD Views: Teams can share PMI-rich models through simple URLs that preserve views and annotations, enabling browser-based access with no exports, plugins, or add-ons required.
  • Feature Tree Awareness: MBD annotations remain intelligently linked to the feature tree, keeping specifications connected to the correct geometry as designs evolve.
  • Downstream-Ready Models can be prepared for inspection and compliance workflows with support for STEP AP242 export and integration with tools such as PC-DMIS and AS9102.

“Cloud-native MBD is a critical step for our customers to build an intelligent, fully digital product lifecycle,” said David Katzman, EVP and General Manager of Onshape and Arena at PTC. “By moving product definition into the cloud, companies can finally break down barriers between design, manufacturing, and the rest of the enterprise. This shift is made possible by AWS’ scalable infrastructure and AI capabilities, which enable Onshape to deliver a faster and more resilient cloud-native platform.”

With Onshape and the rest of its portfolio, PTC is delivering on its vision for the Intelligent Product Lifecycle: enabling manufacturers and product companies to build a product data foundation, extend the value of that data across their enterprise, and accelerate AI-driven transformation. Broader use of product data enables companies to bring higher quality products to market faster, better manage product complexity, meet regulatory and compliance standards, and much more.

For more information on cloud-native MBD in Onshape, visit Model-Based Definition (MBD) in 3D CAD.

To learn more about Onshape, the industry’s only cloud-native CAD and PDM platform, visit www.onshape.com.

About PTC

PTC (NASDAQ: PTC) is a global software company enabling manufacturers and product companies to digitally transform how they design, manufacture, and service products. Headquartered in Boston, Massachusetts, PTC employs over 7,000 people and supports more than 30,000 customers globally. For more information, visit www.ptc.com.

Media Contact
Julia Reed
[email protected] 

Investor Contact
Matt Shimao
[email protected]

PTC, Onshape, and the PTC logo are trademarks or registered trademarks of PTC Inc. and its subsidiaries in the United States and other countries.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptcs-onshape-launches-cloud-native-model-based-definition-capabilities-302698363.html

SOURCE PTC Inc.

Market Opportunity
PATIC Logo
PATIC Price(PTC)
$0,000473
$0,000473$0,000473
+9,49%
USD
PATIC (PTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09